Veterinary Medicines

CLAVASEPTIN P 50 MG TABLETS FOR DOGS AND CATS

Authorised
  • Amoxicillin trihydrate
  • Potassium clavulanate
Download as PDF

Product identification

Medicine name:
CLAVASEPTIN P 50 MG TABLETS FOR DOGS AND CATS
Clavaseptin 50 mg Tablet
Clavaseptin 50 mg Comprimé
Clavaseptin 50 mg Tablette
Active substance:
  • Amoxicillin trihydrate
  • Potassium clavulanate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    45.91
    milligram(s)
    /
    1.00
    Tablet
  • Potassium clavulanate
    11.91
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Cardboard box of 1 blister of 10 tablets
  • Cardboard box of 100 blisters of 10 tablets
  • Cardboard box of 75 blisters of 10 tablets
  • Cardboard box of 60 blisters of 10 tablets
  • Cardboard box of 50 blisters of 10 tablets
  • Cardboard box of 40 blisters of 10 tablets
  • Cardboard box of 30 blisters of 10 tablets
  • Cardboard box of 25 blisters of 10 tablets
  • Cardboard box of 20 blisters of 10 tablets
  • Cardboard box of 15 blisters of 10 tablets
  • Cardboard box of 12 blisters of 10 tablets
  • Cardboard box of 10 blisters of 10 tablets
  • Cardboard box of 5 blisters of 10 tablets
  • Cardboard box of 2 blisters of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Vetoquinol
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V274172
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0407/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
Download
French (PDF)
Published on: 18/08/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
Download
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
Download
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download